MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

A

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Search

Penumbra Inc

Suletud

SektorTervishoid

350.36 12.31

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

312.23

Max

352

Põhinäitajad

By Trading Economics

Sissetulek

581K

46M

Müük

15M

355M

P/E

Sektori keskmine

76.246

90.831

Kasumimarginaal

12.927

Töötajad

4,500

EBITDA

4M

55M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+13% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

17. veebr 2026

Turustatistika

By TradingEconomics

Turukapital

3.7B

13B

Eelmine avamishind

338.05

Eelmine sulgemishind

350.36

Uudiste sentiment

By Acuity

21%

79%

31 / 361 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

Penumbra Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

15. jaan 2026, 13:29 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- 2nd Update

15. jaan 2026, 12:35 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock -- Update

15. jaan 2026, 12:29 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

15. jaan 2026, 14:37 UTC

Kuumad aktsiad

Stocks to Watch Thursday: Goldman Sachs, Boston Scientific, BlackRock -- WSJ

15. jaan 2026, 13:45 UTC

Omandamised, ülevõtmised, äriostud

Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. -- Barrons.com

15. jaan 2026, 12:04 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Penumbra Shareholders Can Elect to Receive Cash or Stock >BSX PEN

15. jaan 2026, 12:03 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Acquisition to Expand Cardiovascular Portfolio >BSX PEN

15. jaan 2026, 12:01 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific: Penumbra Deal Carriers an Enterprise Value of About $14.5 Billion >BSX

15. jaan 2026, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific to Buy Penumbra for $374/Share >BSX PEN

15. jaan 2026, 12:00 UTC

Omandamised, ülevõtmised, äriostud

Boston Scientific Announces Agreement To Acquire Penumbra, Inc. >BSX PEN

Võrdlus sarnastega

Hinnamuutus

Penumbra Inc Prognoos

Hinnasiht

By TipRanks

13% tõus

12 kuu keskmine prognoos

Keskmine 354.17 USD  13%

Kõrge 388 USD

Madal 266 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Penumbra Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

9

Osta

6

Hoia

0

Müü

Tehniline skoor

By Trading Central

288.28 / 292.9394Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

31 / 361 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Penumbra Inc

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
help-icon Live chat